Surveillance Of Emicizumab-Treated Patients: An Analysis of the EUHASS Pharmacovigilance Registry (Emicizumab Pharmacovigilance: EUHASS registry)

23/03/2018
05/02/2026
EU PAS number:
EUPAS23177
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Prot GO40162 Hemlibra v1_Redacted

English (983.2 KB - PDF) View document
Updated protocol

GO40162- Protocol v4_Redacted.pdf

First published: 22/02/2024
English (1.36 MB - PDF) View document
Study results
Study report
Study report

Interim CSR-3_GO40162-Annual Report_01Jul2022_Synopsis_Redacted

English (527.26 KB - PDF) View document

Interim_CSR GO40162_NI-PASS_Annual_Report_030Jun2020_Synopsis_Redacted

English (1.15 MB - PDF) View document

Interim_CSR_2-GO40162_Annual Report_23Jun2021_Synopsis_Redacted

English (443.45 KB - PDF) View document

Interim CSR-4, GO40162-Annual Report 2023_Synopsis_Redacted.pdf

English (1.48 MB - PDF) View document

Interim CSR-5, GO40162-Annual Report 2024_Synopsis_Redacted.pdf

English (384.64 KB - PDF) View document

Interim CSR-6, GO40162-Annual Report 2025_Synopsis_Redacted.pdf

English (387.53 KB - PDF) View document
Other information